Answers are grounded in this paper and cite their sources.
Background Falls commonly cause increased mortality and morbidity. Medications are a modifiable risk factor. This systematic review and meta-analysis examines falls risk associated with individual and combination psychotropics. Methods Update and extension of a systematic review with meta-analysis of studies reporting the association between psychotropics and falls in people aged ≥ 60 years. Included medications were: antipsychotics, antidepressants, benzodiazepines, and opioids (updated); and z-drugs, gabapentinoids, and combination psychotropics (extended scope). Studies included in the previous review were re-screened to remove ineligible cross-sectional studies, and new studies identified by rerunning the search (Additional file 1: Boxes S1-S3) in Embase/Medline/PsycINFO from 29/09/16 to 18/01/24. Generic inverse variance meta-analysis was used to calculate pooled adjusted separate effect estimates of falls risk except for gabapentinoids where narrative synthesis was used. Quality and risk of bias were assessed using The Newcastle Ottawa Scale and Cochrane ROB-2 tool for observational studies and clinical trials respectively. Results Adjusted effect estimates of fall risk from 121 studies were meta-analysed, with adjusted odds ratios (aORs) being most common. The aOR (95%CI) of falling were statistically significant for exposure versus non-exposure to: antipsychotics (1.40, 1.24–1.57; n = 28 estimates), antidepressants (1.66, 1.54–1.79; n = 65), benzodiazepines (1.60, 1.40–1.82; n = 39), z-drugs (1.74, 1.34–2.27; n = 8) and opioids (1.48, 1.28–1.71; n = 36). There was limited evidence for gabapentinoids (2 studies). aORs of falling were modestly higher for long-acting (1.61, 1.34–1.94; n = 14) compared to short-intermediate acting (1.33, 1.21–1.46; n = 8) benzodiazepines. Increased association of fall risk was seen for: atypical (aHR 1.76, 1.39–2.22; n = 4) and typical (aHR 1.47, 1.18–1.84; n = 3) antipsychotics; tricyclic (aOR 1.58, 1.24–2.01; n = 14) and SSRI (aOR 1.77, 1.48–2.12; n = 13) antidepressants. Fall risk appeared greater in studies examining hospital settings than community for antipsychotics, benzodiazepines and z-drugs. Fall risk increased with increasing psychotropic exposure (aOR 1.37, 1.24 to 1.53 for single psychotropic vs. 1.88, 1.45 to 2.43 for 2 psychotropics) but then plateaued (1.60, 1.40 to 1.83 for 3 + psychotropics). Meta-analysis of other effect estimates (risk ratios, hazard ratios) were consistent, but heterogeneity was generally high. Conclusions The psychotropics examined were associated with an increased falls risk, with additional risk from multiple psychotropic exposures. Data on fall risk associated with gabapentinoids are limited.
No takes yet. Share an insight, caveat, or question.
Al‐Din et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: